Aytu Biopharma's three largest insider shareholders as of April 22, 2026 are Gary Cantrell (Director, 164.09K shares), Jarrett Disbrow (Chief Business Officer, 61.57K shares), Ryan J Selhorn (Chief Financial Officer, 49.74K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Gary Cantrell | - | 164,089 | 0 | 23 Dec, 2022 |
| Jarrett Disbrow | Chief Business Officer | 61,568 | 0 | 07 Oct, 2025 |
| Ryan J Selhorn | Chief Financial Officer | 49,743 | 0 | 07 Oct, 2025 |
| Greg Pyszczymuka | Chief Commercial Officer | 36,102 | 0 | 07 Oct, 2025 |
| Greg Pyszczymuka | Chief Commercial Officer | 23,602 | 0 | 31 Mar, 2025 |
| Carl Dockery | - | 20,440 | 0 | 07 Oct, 2025 |
| Ryan J Selhorn | Chief Financial Officer | 16,000 | 0 | 03 Mar, 2025 |
| John Jr. Donofrio | - | 13,762 | 0 | 07 Oct, 2025 |
| Carl Dockery | - | 10,440 | 0 | 08 Nov, 2024 |
| John Jr. Donofrio | - | 3,762 | 0 | 08 Nov, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 03 Oct, 2025 | Jarrett Disbrow | Common Stock | A | 19,606 | $0.00 | 49,068 | D | A |
| 03 Oct, 2025 | John Jr. Donofrio | Common Stock | A | 10,000 | $0.00 | 13,762 | D | A |
| 03 Oct, 2025 | Greg Pyszczymuka | Common Stock | A | 12,500 | $0.00 | 36,102 | D | A |
| 03 Oct, 2025 | Ryan J Selhorn | Common Stock | A | 16,243 | $0.00 | 32,243 | D | A |
| 03 Oct, 2025 | Carl Dockery | Common Stock | A | 10,000 | $0.00 | 20,440 | D | A |
| 03 Oct, 2025 | Jarrett Disbrow | Common Stock | A | 12,500 | $0.00 | 61,568 | D | A |
| 03 Oct, 2025 | Ryan J Selhorn | Common Stock | A | 17,500 | $0.00 | 49,743 | D | A |
| 09 Jun, 2025 | Jarrett Disbrow | Common Stock | A | 16,666 | $1.50 | 29,462 | D | P |
| 31 Mar, 2025 | Greg Pyszczymuka | Common Shares | A | 209 | - | 23,602 | D | M |
| 31 Mar, 2025 | Greg Pyszczymuka | Restricted Stock Units | D | 209 | $0.00 | 0 | D | M |
| 05 Feb, 2025 | Ryan J Selhorn | Common Shares | A | 105 | - | 16,000 | D | M |
| 05 Feb, 2025 | Ryan J Selhorn | Restricted Stock Units | D | 105 | $0.00 | 0 | D | M |
| 31 Dec, 2024 | Greg Pyszczymuka | Common Shares | A | 208 | - | 23,393 | D | M |
| 31 Dec, 2024 | Greg Pyszczymuka | Restricted Stock Units | D | 208 | $0.00 | 209 | D | M |
| 11 Nov, 2024 | Ryan J Selhorn | Common Shares | A | 14,000 | $0.00 | 15,895 | D | A |
| 06 Nov, 2024 | Carl Dockery | Common Shares | A | 1,500 | $0.00 | 10,440 | D | A |
| 06 Nov, 2024 | John Jr. Donofrio | Common Shares | A | 1,500 | $0.00 | 3,762 | D | A |
| 06 Nov, 2024 | Greg Pyszczymuka | Employee Stock Option (Right to Buy) | A | 7,000 | $0.00 | 7,000 | D | A |
| 06 Nov, 2024 | Jarrett Disbrow | Employee Stock Option (Right to Buy) | A | 7,000 | $0.00 | 7,000 | D | A |
| 30 Sep, 2024 | Greg Pyszczymuka | Common Shares | A | 209 | - | 23,185 | D | M |